SCHEMBL21933858

SCHEMBL21933858

Nc1ccccc1-c1ccccc1-c1cccc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ATM Q13315 1/20 0.46
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 1/20 0.39
IL1R1 P14778 1/20 0.36
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
MEN1 O00255 1/20 0.35
ASH1L Q9NR48 5/20 0.35
KEAP1 Q14145 2/20 0.35
NFE2L2 Q16236 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
HSPA1A P0DMV8 1/20 0.33
PABPC1 P11940 1/20 0.33
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DHFR P00374 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21446200 0.94 L3MBTL1 (0.48) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL12853965 0.91 L3MBTL1 (0.55) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL64366 0.91 L3MBTL1 (0.55) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL19075915 0.89 L3MBTL1 (0.57) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL24295147 0.87 L3MBTL1 (0.57) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL19755546 0.86 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1IL1R1
SCHEMBL21098259 0.85 L3MBTL1 (0.51) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL26608962 0.83 L3MBTL1 (0.47) L3MBTL1KDM4EATMALDH1A1IL1R1
SCHEMBL17468688 0.83 KDM4E (0.49) L3MBTL1KDM4EATMALDH1A1HSD17B10
SCHEMBL16674035 0.83 ATM (0.50) L3MBTL1KDM4EATMALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME HEESUNG MATERIAL LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 L3MBTL1 1245/4885KDM4E 2576/4885ATM 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.